Oppenheimer Starts Insulet (PODD), Thoratec (THOR) at Outperform, DexCom (DXCM), HeartWare (HTWR) at Perform

In the Medical Equipment & Supplies group Wednesday morning, an analyst at Oppenheimer initiated coverage on the following stocks:

• Insulet (Nasdaq: PODD) with an Outperform rating and a $25 price target
  
• Thoratec (Nasdaq: THOR) with an Outperform rating and a $40 price target
  
• DexCom (Nasdaq: DXCM) with a Perform rating
  
• HeartWare (Nasdaq: HTWR) with a Perform rating

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
• BMO Capital Starts Analog Devices (ADI) at Outperform
• Raymond James Starts Southern California Bancorp (BCAL) at Outperform